Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1995Journal of Clinical Oncology

Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation.

View Full Paper
Ask AI
Bookmark
Share

Authors

RCR ColwillOntario Institute for Cancer ResearchMCMichael CrumpUniversity Health NetworkFCFélix CoutureHôtel-Dieu de Québec

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Colwill et al. (1995) studied this question.

synapsesocial.com/papers/6a0ef55d53f874f2b222ffe2https://doi.org/10.1200/jco.1995.13.2.396
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Combined chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease.An alternative program to MOPP1976 · 40 citations
  2. 2Mini‐BEAM followed by BEAM and ABMT for very poor risk Hodgkin's disease1992 · 66 citations
  3. 3Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.1989 · 210 citations
  4. 4The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight- year study of 155 patients1993 · 320 citations
  5. 5Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation1989 · 199 citations